Skip to content

The Finnish randomised controlled multicentre trial on optimal timing of labor induction in nulliparous women with post-term pregnancy

The Finnish randomised controlled multicentre trial comparing induction of labor at 41+0 gestational weeks with expectant management and labor induction at 41+5 - 42+1 gestational weeks in nulliparous women with an unfavourable cervix

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN83219789
Enrollment
600
Registered
2017-10-10
Start date
2018-03-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nulliparity and post-term pregnancy Pregnancy and Childbirth Nulliparity and post-term pregnancy

Interventions

Current version as of 04/04/2018: Randomisation is performed by computer-sequenced block randomisation technique. The first randomisation (timing of labour induction) is performed at 41+0 gestational

Sponsors

Helsinki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Pregnant women 2. Age =18 years 3. Nulliparous 4. Gestational age 41+0 weeks 5. Singleton pregnancy 6. Live fetus 7. Cephalic presentation 8. Intact amniotic membranes 9. Unfavourable cervix (Bishop score < 6) 10. Uncomplicated pregnancy (no pregnancy complications that require induction of labour) 11. Ability to understand oral and written information

Exclusion criteria

Exclusion criteria: 1. Multiple pregnancy 2. Breech or transverse presentation 2. Fetal malformation detected antenatally 3. Multiparous women 4. Women with a history of previous caesarean section or transfundal uterine surgery 5. Pregnancy complication that requires intervention (such as preeclampsia, intrauterine growth restriction, pregestational diabetes and insulin-dependent gestational diabetes) 6. Premature rupture of membranes 7. Clinical vaginal infection or chorionamnionitis 8. Fetal macrosomia (antenatally estimated weight = 4.5 kg) 9. Maternal HIV, hepatitis B or C 10. Contraindication for vaginal delivery (such as low lying placenta or vasa previa) 11. No informed consent received

Design outcomes

Primary

MeasureTime frame
The rate of caesarean section is measured at birth using the mode of delivery.

Secondary

MeasureTime frame
Current version as of 04/04/2018: 1. Primary neonatal outcome are measured using 1 and 5 minute Apgar scores, umbilical artery blood pH and base excess values at birth, and intubation at birth 2. Neonatal intensive care episodes is measured using patient notes on admissions to neonatal intensive care unit during the first 24 hours after birth 3. Neonatal care episodes is measured using patient notes on admissions to neonatal ward during the first 24 hours after birth 4. Placental retention is measured at 1 hour from birth using the definition that surgical or pharmacological interventions are needed for placental expulsion 5. Maternal haemorrhage is measured by volume of bleeding in milliliters or weight of bleeding in grams at birth 6. Perineal tears is measured using sphincter injury at birth 7. Intrapartum and postpartum infections is measured at labour and during post-partum care episode, using any two of the criteria: maternal fever = 38°C, fetal tachycardia, purulent discharge, uterine tenderness, and white cell count > 20 8. Maternal satisfaction is measured using Childbirth Experience questionnaire (CEQ) Original version: 1. Primary neonatal outcome are measured using 1 and 5 minute Apgar scores, umbilical artery blood pH and base excess values at birth, and intubation at birth 2. Neonatal intensive care episodes is measured using patient notes on admissions to neonatal intensive care unit during the first 24 hours after birth 3. Neonatal care episodes is measured using patient notes on admissions to neonatal ward during the first 24 hours after birth 4. Placental retention is measured at 1 hour from birth using the definition that surgical or pharmacological interventions are needed for placental expulsion 5. Maternal haemorrhage is measured by volume of bleeding in milliliters or weight of bleeding in grams at birth 6. Perineal tears is measured using sphincter injury at birth 7. Intrapartum and postpartum infections is measured at labour and during post

Countries

Finland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 7, 2026